Wednesday, March 29, 2023
Clinical Advances in
Osteoarthritis affects more than 30 million Americans, making it the most common form of arthritis. With an aging population and increasing rates of obesity, the number of people with osteoarthritis continues to grow. It is important for clinicians to diagnose osteoarthritis early and subsequently develop individualized treatment strategies based on the degree of arthritis and disability and on any comorbidities that the patient may have. This page provides education on the management of osteoarthritis, including use of intra-articular steroids and therapy sequence.
Supported by an independent educational grant from
Flexion Therapeutics Inc.
A glance at diagnosis and pharmacotherapy for patients with osteoarthritis of the knee.
Download
Steering Committee Chair
Associate Professor
Chair
Geisel School of Medicine
Dartmouth College
Lebanon, New Hampshire
Professor of Medicine
Hospital for Special Surgery
New York, New York
President
Altoona Arthritis and Osteoporosis Center
Altoona Center for Clinical Research
Duncansville, Pennsylvania
Professor
Duke University School of Medicine
Durham, North Carolina
Professor of Orthopedic Surgery
Tufts University School of Medicine
Medical Director, Network Development
New England Baptist Hospital
Boston, Massachusetts
Orthopedic Surgeon
Co-Director
Joint Replacement Program
Cedars-Sinai Orthopedic Center
Cedars-Sinai Medical Center
Los Angeles, California
Steering Committee Chair
Has disclosed the following relevant financial relationships
Served as a speaker or a member of a speakers bureau for: Medacta USA
Received grants for clinical research from: Depuy Synthes
Owns stock, stock options, or bonds from: Risalto Healthcare
Has disclosed the following relevant financial relationships
Served as an advisor or consultant for: AbbVie Inc.; Celgene Corporation; Flexion Therapeutics; Lilly; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; Takeda Pharmaceuticals North America, Inc.
Served as a speaker or a member of a speakers bureau for: AbbVie Inc.; Celgene Corporation; Flexion Therapeutics; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.
Owns stock, stock options, or bonds from: AbbVie Inc.; Amgen Inc.; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Regeneron
Has disclosed no relevant financial relationships
Has disclosed the following relevant financial relationships
Served as an advisor or consultant for: GlaxoSmithKline; KOLON TissueGene; Novartis Pharmaceuticals Corporation; Unity Biotechnology
Received grants for clinical research from: Bayer HealthCare; Zimmer
Owns stock, stock options, or bonds from: Unity Biotechnology
Has disclosed the following relevant financial relationships
Served as an advisor or consultant for: Flexion Therapeutics; Histogenics
Served as a speaker or a member of a speakers bureau for: Flexion Therapeutics
Has disclosed the following relevant financial relationships
Served as an advisor or consultant for: DePuy Synthes Companies; Fidia Pharma USA Inc; Flexion Therapeutics; Sanofi; Zimmer Biomet
Served as a speaker or a member of a speakers bureau for: Zimmer Biomet
Received grants for clinical research from: Flexion Therapeutics